# Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium

> **NCT06541080** · — · RECRUITING · sponsor: **University Hospital, Antwerp** · enrollment: 550 (estimated)

## Conditions studied

- Neuroendocrine Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Shallow Whole Genome Sequencing (sWGS)-GIPXplore
- **DIAGNOSTIC_TEST:** methylation-sensitive restriction enzymes (MSRE)-Single-molecule molecular inversion probes (smMIP)-seq assay

## Key facts

- **NCT ID:** NCT06541080
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-03
- **Primary completion:** 2028-12-04
- **Final completion:** 2030-12-04
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2024-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06541080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06541080, "Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06541080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*